Tag: Duvelisib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Duvelisib

AJ Wealth Strategies LLC Sells 56995 Shares of Verastem Inc (NASDAQ:VSTM)

Added to Collection on: 2019-06-13 18:30:00

Tags for this article:

Stock
Oncology
Verastem Inc.
Duvelisib
Verastem Oncology

Click the tags to see associated articles and topics

View Article Details
Verastem (NASDAQ:VSTM) Lifted to Hold at Zacks Investment Research

Added to Collection on: 2019-07-13 21:41:15

Tags for this article:

Money
Finance
Economy
Stock
Short
Oncology
Securities research
Verastem Inc.
Duvelisib
Price–earnings ratio
Verastem Oncology
Phosphoinositide 3-kinase

Click the tags to see associated articles and topics

View Article Details
Infinity Pharmaceuticals, Inc. (INFI) EPS Estimated At $-0.15

Added to Collection on: 2019-07-25 06:30:00

Tags for this article:

Economy
Medicine
Clinical medicine
Short
Oncology
Limited
Duvelisib
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
Renaissance Technologies LLC Has $1.48 Million Stake in Verastem Inc (NASDAQ:VSTM)

Added to Collection on: 2019-10-06 19:37:30

Tags for this article:

Financial markets
Drugs
Duvelisib
Oncology
Finance
Stock market
Price?earnings ratio
Visual short-term memory
Stock
Verastem Oncology
Verastem Inc.

Click the tags to see associated articles and topics

View Article Details
HC Wainwright Reaffirms "Buy" Rating for Verastem (NASDAQ:VSTM)

Added to Collection on: 2021-03-20 11:03:06

Tags for this article:

Financial markets
Drugs
Finance
Duvelisib
Oncology
Stock
BlackRock
Verastem Oncology
VERASTEM

Click the tags to see associated articles and topics

View Article Details
AACR: In redemption of the PI3K drug class, Bayer's Aliqopa leaps ahead of Gilead's Zydelig in ...

Added to Collection on: 2021-04-10 18:33:45

Tags for this article:

Drugs
Health sciences
Life Sciences
Antineoplastic drugs
Breakthrough therapy
Orphan drugs
Specialty drugs
Drug discovery
Phosphoinositide 3-kinase inhibitor
Verastem Oncology
Duvelisib
Umbralisib
Scott Fields

Click the tags to see associated articles and topics

View Article Details
Chronic Lymphocytic Leukemia (CLL) Treatment Market Overview, SWOT Analysis, COVID-19 ...

Added to Collection on: 2021-06-16 04:07:30

Tags for this article:

Orphan drugs
Clinical medicine
Tyrosine kinase inhibitors
Drugs
Chronic lymphocytic leukemia
CLL
Leukemia
Health care
Antineoplastic drugs
Ibrutinib
Duvelisib

Click the tags to see associated articles and topics

View Article Details
Small Lymphocytic Lymphoma Market Expected to Grow at a CAGR of 2.9% during 2025 ...

Added to Collection on: 2025-02-14 19:10:23

Tags for this article:

Orphan drugs
Antineoplastic drugs
Ibrutinib
Bruton's tyrosine kinase
Chronic lymphocytic leukemia
Indolent lymphoma
Duvelisib
Acalabrutinib
Lisocabtagene maraleucel
B-cell lymphoma
Lymphoma
Targeted therapy

Click the tags to see associated articles and topics

View Article Details
Yingli Pharma gains FDA approval for Phase III trial of r/r PTCL drug candidate

Added to Collection on: 2025-04-02 17:03:31

Tags for this article:

Orphan drugs
Anatomical pathology
Hematology
Lymphoma
Yingli
Antineoplastic drugs
Duvelisib
Kite Pharma

Click the tags to see associated articles and topics

View Article Details
Roche's Lunsumio: A Regulatory and Market Breakthrough in Oncology - AInvest

Added to Collection on: 2025-09-20 23:33:53

Tags for this article:

Orphan drugs
Mosunetuzumab
Committee for Medicinal Products for Human Use
Duvelisib

Click the tags to see associated articles and topics

View Article Details
Book a Demo